Published in Appl Environ Microbiol on February 01, 1986
Bacterial vaginosis. Clin Microbiol Rev (1991) 2.27
Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol (2008) 1.76
Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol (2005) 1.52
Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.50
Qualitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.47
The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol (2008) 1.37
Clostridium clostridioforme: a mixture of three clinically important species. Eur J Clin Microbiol Infect Dis (2005) 1.29
Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women. Sex Transm Infect (2005) 1.27
Complete genome sequence and lifestyle of black-pigmented Corynebacterium aurimucosum ATCC 700975 (formerly C. nigricans CN-1) isolated from a vaginal swab of a woman with spontaneous abortion. BMC Genomics (2010) 1.20
Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus. J Clin Microbiol (1989) 1.17
Multiplex detection of bacteria associated with normal microbiota and with bacterial vaginosis in vaginal swabs by use of oligonucleotide-coupled fluorescent microspheres. J Clin Microbiol (2009) 1.16
Quantitative microbiologic models for preterm delivery. J Clin Microbiol (2003) 1.10
Clinical safety-in-use study of a new tampon design. Infect Dis Obstet Gynecol (2003) 0.98
The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm. Genitourin Med (1991) 0.94
The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev (2016) 0.91
Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005. J Clin Microbiol (2007) 0.90
Regulation of cell component production by growth rate in the group B Streptococcus. J Bacteriol (1999) 0.89
Mixed-effect models for predicting microbial interactions in the vaginal ecosystem. J Clin Microbiol (1994) 0.86
A prospective, randomized, double-blind study of vaginal microflora and epithelium in women using a tampon with an apertured film cover compared with those in women using a commercial tampon with a cover of nonwoven fleece. J Clin Microbiol (2007) 0.85
Chlamydia caviae infection alters abundance but not composition of the guinea pig vaginal microbiota. Pathog Dis (2015) 0.79
Randomized, double-blind crossover study of vaginal microflora and epithelium in women using a tampon with a "winged" apertured film cover and a commercial tampon with a nonwoven fleece cover. J Clin Microbiol (2010) 0.75
Site-specific prevalence and cell densities of selected microbes in the lower reproductive tract of menstruating tampon users. Infect Dis Obstet Gynecol (2002) 0.75
Absence of significant cellulase activity in microbial flora of the female genital tract. Infect Immun (1987) 0.75
Quantitative bacteriology of the vaginal flora. J Infect Dis (1977) 3.81
Vaginal flora in asymptomatic women. Mayo Clin Proc (1976) 2.49
Sequential vaginal cultures from normal young women. J Clin Microbiol (1980) 2.17
Normal vaginal microbiology of women of childbearing age in relation to the use of oral contraceptives and vaginal tampons. J Clin Pathol (1967) 2.13
Methods for quantitative vaginal flora studies. Am J Obstet Gynecol (1977) 2.05
Bacterial flora of the cervix from 100 prehysterectomy patients. Am J Obstet Gynecol (1975) 1.82
Anaerobic microflora of the cervix in healthy women. Am J Obstet Gynecol (1973) 1.78
Quantitative studies of the vaginal flora of healthy women and of obstetric and gynaecological patients. J Med Microbiol (1978) 1.63
Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. Am J Obstet Gynecol (1978) 1.39
Bacterial flora of the vagina during the menstrual cycle: findings in users of tampons, napkins, and sea sponges. Ann Intern Med (1982) 1.27
A study of the microbiological flora of the vagina. Am J Obstet Gynecol (1958) 1.17
Vaginal flora in women undergoing hysterectomy with antibiotic prophylaxis. Obstet Gynecol (1979) 0.96
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68
The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature (1987) 7.06
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology (1978) 5.91
Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis (1986) 5.12
Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1993) 4.92
The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med (1992) 4.88
The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med (1990) 4.25
Bacteriuria of pregnancy--a critical appraisal. Annu Rev Med (1968) 3.95
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
Quantitative bacteriology of the vaginal flora. J Infect Dis (1977) 3.81
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis (1977) 3.62
Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int (2006) 3.48
Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med (1995) 3.46
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol (2001) 3.44
Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest (1976) 3.34
Familial aggregation of blood pressure in childhood. N Engl J Med (1971) 3.27
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
THE OCCURRENCE OF NORMAL SERUM GAMMA-GLOBULIN IN HUMAN LYMPHOCYTES. Science (1945) 3.21
Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis (2000) 3.20
Colitis induced by Clostridium difficile. Rev Infect Dis (1980) 3.15
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA (1992) 3.07
Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol (2007) 3.04
Risk of local and systemic infection with polyethylene intravenous catheters. A prospective study of 213 catheterizations. N Engl J Med (1968) 3.00
Structural features of polysaccharides that induce intra-abdominal abscesses. Science (1993) 2.86
Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol (1970) 2.83
Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature (1989) 2.78
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene (2006) 2.69
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA (1991) 2.51
Thomas Hodgkin and Benjamin Harrison: crisis and promotion in academia. Med Hist (1980) 2.44
A retrospective cohort study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1988) 2.38
Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun (1981) 2.34
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Antibacterial mechanisms of the urinary bladder. J Clin Invest (1968) 2.31
v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell (1990) 2.31
The genital mycoplasmas. N Engl J Med (1973) 2.21
Significance of blood pressure in infancy. Familial aggregation and predictive effect on later blood pressure. Hypertension (1985) 2.20
Longitudinal study of the effects of maternal smoking on pulmonary function in children. N Engl J Med (1983) 2.19
Clostridium difficile in gnotobiotic mice. Infect Immun (1980) 2.17
Mechanisms of antibacterial action in the respiratory system. Bacteriol Rev (1966) 2.15
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
Susceptibility of genital mycoplasmas to antimicrobial agents. Appl Microbiol (1970) 2.13
Age-specific correlation analysis of longitudinal blood pressure data. Am J Epidemiol (1977) 2.10
Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med (1995) 2.08
A case-control study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1987) 2.07
Methods for quantitative vaginal flora studies. Am J Obstet Gynecol (1977) 2.05
The influence of bacterial species on pulmonary resistance to infection in mice subjected to hypoxia, cold stress, and ethanolic intoxication. Br J Exp Pathol (1965) 2.03
Methodologic investigations and prevalence of genital mycoplasmas in pregnancy. J Infect Dis (1970) 2.02
Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Intern Med (1992) 1.99
Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology (1978) 1.98
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. J Acquir Immune Defic Syndr (1989) 1.96
Bacteremia due to serratia marcescens. N Engl J Med (1968) 1.96
Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun (1991) 1.95
The multicenter AIDS Cohort Study, 1983 to …. Public Health (2011) 1.93
Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst (1999) 1.92
Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest (1995) 1.91
Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology (1994) 1.88
Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol (1997) 1.86
A simple method for quantitative urine culture. N Engl J Med (1967) 1.85
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS (2001) 1.84
Serologic typing of human genital T-mycoplasmas by a complement-dependent mycoplasmacidal test. J Infect Dis (1972) 1.82
Neonatal mouse model of group B streptococcal infection. J Infect Dis (1992) 1.82
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother (1981) 1.81
The role of the intestinal microflora in experimental colitis. Am J Clin Nutr (1977) 1.80
Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS (2001) 1.79
A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend (1999) 1.78
Effect of total leucocyte count on whole blood filterability in patients with peripheral vascular disease. J Clin Pathol (1981) 1.78
Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1991) 1.76
Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr (1979) 1.75
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev (1997) 1.75
Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother (1977) 1.75
Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation (1978) 1.75
Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med (1998) 1.74
Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis (1977) 1.74
Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J (1999) 1.73
Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J Infect Dis (1997) 1.71
Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med (1989) 1.67
Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J Infect Dis (1987) 1.66
Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res (1978) 1.66
Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1992) 1.66
Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Multicentre AIDS Cohort Study. Stat Med (1990) 1.65
Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr (1992) 1.65
Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1990) 1.65
Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol (1997) 1.63
Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med (1982) 1.62
Effect of dissolved oxygen and Eh and Bacteroides fragilis during continuous culture. Appl Environ Microbiol (1976) 1.62
Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59
Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore) (1967) 1.58
Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol (1991) 1.57
Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect (1999) 1.57
Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol (2000) 1.57
Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1992) 1.57
T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem (2000) 1.57